Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.84B |
| 2 |
Autodesk
ADSK
|
+$682M |
| 3 |
Atlassian
TEAM
|
+$647M |
| 4 |
Vertiv
VRT
|
+$624M |
| 5 |
Netflix
NFLX
|
+$612M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.39B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.15B |
| 3 |
Visa
V
|
+$855M |
| 4 |
Cadence Design Systems
CDNS
|
+$765M |
| 5 |
Eli Lilly
LLY
|
+$733M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Financials | 20.23% |
| 3 | Industrials | 12.47% |
| 4 | Healthcare | 11.09% |
| 5 | Consumer Discretionary | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
MiMedx Group
MDXG
$609M
| $1.67M | ﹤0.01% |
173,743
-5,189
| -3% | -$40.4K |
|
777
Qfin Holdings
QFIN
$1.59B
| $1.65M | ﹤0.01% |
+42,990
| New | +$1.49M |
|
|
BRY
778
DELISTED
Berry Corp
BRY
| $1.63M | ﹤0.01% |
395,396
+37,671
| +11% | +$174K |
|
779
Lumen
LUMN
$6.09B
| $1.6M | ﹤0.01% |
+302,141
| New | +$2.08M |
|
780
Bread Financial
BFH
$4.44B
| $1.59M | ﹤0.01% |
26,098
-779
| -3% | -$44K |
|
781
KE Holdings
BEKE
$18.7B
| $1.58M | ﹤0.01% |
+85,718
| New | +$1.77M |
|
|
CPRX
782
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.58M | ﹤0.01% |
75,494
-2,253
| -3% | -$48.4K |
|
783
Navient
NAVI
$892M
| $1.54M | ﹤0.01% |
115,687
-3,452
| -3% | -$51.6K |
|
784
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.49M | ﹤0.01% |
25,502
-762
| -3% | -$45.7K |
|
785
Perimeter Solutions
PRM
$6.11B
| $1.45M | ﹤0.01% |
+113,085
| New | +$1.48M |
|
786
Beam Therapeutics
BEAM
$2.81B
| $1.39M | ﹤0.01% |
56,027
-1,671
| -3% | -$42.6K |
|
|
ZEUS
787
DELISTED
Olympic Steel
ZEUS
| $1.37M | ﹤0.01% |
41,906
+2,559
| +7% | +$99.2K |
|
788
Amneal Pharmaceuticals
AMRX
$5.77B
| $1.35M | ﹤0.01% |
170,978
-19,684
| -10% | -$165K |
|
789
Blue Bird Corp
BLBD
$2.09B
| $1.35M | ﹤0.01% |
+34,824
| New | +$1.45M |
|
790
Rockwell Automation
ROK
$49.2B
| $1.34M | ﹤0.01% |
4,686
-580
| -11% | -$163K |
|
791
Twist Bioscience
TWST
$6.84B
| $1.32M | ﹤0.01% |
28,465
-849
| -3% | -$38.4K |
|
|
RYZ
792
Ryerson Holding Corp
RYZ
$1.4B
| $1.32M | ﹤0.01% |
71,426
-2,131
| -3% | -$47.8K |
|
793
Copa Holdings
CPA
$5.8B
| $1.31M | ﹤0.01% |
14,880
+2,112
| +17% | +$200K |
|
794
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $1.28M | ﹤0.01% |
64,881
-1,935
| -3% | -$44.2K |
|
795
Constellium
CSTM
$3.88B
| $1.28M | ﹤0.01% |
124,681
+15,038
| +14% | +$185K |
|
|
ACH
796
Accendra Health
ACH
$224M
| $1.28M | ﹤0.01% |
97,901
-2,922
| -3% | -$39K |
|
797
Nurix Therapeutics
NRIX
$2.62B
| $1.27M | ﹤0.01% |
67,404
-2,011
| -3% | -$46.1K |
|
798
Protagonist Therapeutics
PTGX
$9.4B
| $1.25M | ﹤0.01% |
+32,449
| New | +$1.41M |
|
799
UFP Industries
UFPI
$5.19B
| $1.25M | ﹤0.01% |
11,099
+1,339
| +14% | +$173K |
|
800
Alkermes
ALKS
$8.11B
| $1.25M | ﹤0.01% |
43,398
-10,123
| -19% | -$291K |
|
Similar funds
Massachusetts Financial Services's Q4 2024 Portfolio in Review
As of Q4 2024, Massachusetts Financial Services held 934 positions worth $317B, down 5.4% from $335B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Massachusetts Financial Services withdrew a net $17.2B in Q4 2024, closing 59 positions and reducing 501 holdings. Its most notable exit was West Pharmaceutical, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
Against the trend, Massachusetts Financial Services opened a new position in Atlassian worth $687M.
- Massachusetts Financial Services's largest Q4 2024 buy was Atlassian: 2,824,742 shares worth $687M.
- Massachusetts Financial Services added most to Tesla in Q4 2024, an estimated $1.84B increase.
- Massachusetts Financial Services's biggest Q4 2024 reduction was Microsoft, cutting an estimated $1.39B.
- Massachusetts Financial Services fully exited West Pharmaceutical in Q4 2024, selling an estimated $173M.
- Massachusetts Financial Services's ten largest holdings make up 21% of its $317B portfolio in Q4 2024.
- Massachusetts Financial Services opened 87 new positions and closed 59 in Q4 2024.
- Massachusetts Financial Services's portfolio value fell 5.4% quarter-over-quarter to $317B.
Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.